A Spontaneously Arising Pancreatic Tumor Does Not Promote the Differentiation of Naive CD8+ T Lymphocytes into Effector CTL
- 1 June 2004
- journal article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 172 (11) , 6558-6567
- https://doi.org/10.4049/jimmunol.172.11.6558
Abstract
In this report, we address whether a growing tumor provides sufficient inflammatory signals to promote activation, clonal expansion, and acquisition of effector functions by naive tumor-specific CD8+ T lymphocytes. CD8+ T lymphocytes obtained from hemagglutinin (HA)-specific clone 4 TCR-transgenic mice were injected into recipient mice that spontaneously develop pancreatic tumors expressing HA as a tumor-associated Ag (RIP-Tag2-HA mice). When 3 × 106 clone 4 CD8+ T cells were transferred into tumor-bearing mice, the cells became activated in the pancreatic lymph nodes where they proliferated and acquired effector functions such as cytolytic activity and IFN-γ production. Surprisingly, reducing the number of adoptively transferred CD8+ T cells led to a parallel reduction in the proportion of the activated cells that exhibited effector functions, suggesting that CTL differentiation was induced by the large numbers of activated CD8+ T cells and not the tumor environment. Provision of tumor-specific CD4+ helper cells provided the signals required to promote both the development of CTL effector functions and increased clonal expansion, resulting in tumor eradication. Considering that only small numbers of tumor-specific CD8+ T cells would be present in a conventional T cell repertoire, these data suggest that tumor growth alone may not provide the inflammatory signals necessary to support the development of CD8+ T cell effector functions.Keywords
This publication has 50 references indexed in Scilit:
- Signal 3 Determines Tolerance versus Full Activation of Naive CD8 T CellsThe Journal of Experimental Medicine, 2003
- Efficient Targeting of Protein Antigen to the Dendritic Cell Receptor DEC-205 in the Steady State Leads to Antigen Presentation on Major Histocompatibility Complex Class I Products and Peripheral CD8+ T Cell ToleranceThe Journal of Experimental Medicine, 2002
- Compromised Influenza Virus-Specific CD8+-T-Cell Memory in CD4+-T-Cell-Deficient MiceJournal of Virology, 2002
- Cancer immunoediting: from immunosurveillance to tumor escapeNature Immunology, 2002
- Uncoupling of Proliferative Potential and Gain of Effector Function by CD8+ T Cells Responding to Self-AntigensThe Journal of Experimental Medicine, 2002
- Tumor Growth Enhances Cross-Presentation Leading to Limited T Cell Activation without ToleranceThe Journal of Experimental Medicine, 2002
- Phenotypic and Functional Analysis of Cd8+ T Cells Undergoing Peripheral Deletion in Response to Cross-Presentation of Self-AntigenThe Journal of Experimental Medicine, 2001
- The Induction of Tolerance by Dendritic Cells That Have Captured Apoptotic CellsThe Journal of Experimental Medicine, 2000
- Thymic selection of CD8+ single positive cells with a class II major histocompatibility complex-restricted receptor.The Journal of Experimental Medicine, 1994
- Ablation of “tolerance” and induction of diabetes by virus infection in viral antigen transgenic miceCell, 1991